|2.11||+0.0500||+2.43%||Vol 1.03M||1Y Perf -55.51%|
|Jun 27th, 2022 16:00 DELAYED|
|- -||- -%|
|Target Price||7.40||Analyst Rating||Strong Buy 1.00|
|Potential %||250.71||Finscreener Ranking||★★★+ 51.82|
|Insiders Trans % 3/6/12 mo.||-100/20/-||Value Ranking||★ 40.05|
|Insiders Value % 3/6/12 mo.||-100/30/-24||Growth Ranking||★ 37.62|
|Insiders Shares Cnt. % 3/6/12 mo.||-100/28/-16||Income Ranking||— -|
|Price Range Ratio 52W %||9.69||Earnings Rating||Sell|
|Market Cap||195.81M||Earnings Date||10th Aug 2022|
Today's Price Range
5 Year PE Ratio Range
|Earnings History||Estimate||Reported||Surprise %|
|Earnings Per End||Estimate||Revision %||Trend|
|Next Report Date||10th Aug 2022|
|Estimated EPS Next Report||-0.05|
|EPS Growth Next 5 Years %||-|
|Avg. Weekly Volume||4.02M|
|Avg. Monthly Volume||1.75M|
|Avg. Quarterly Volume||1.13M|
Accuray Incorporated (NASDAQ: ARAY) stock closed at 2.06 per share at the end of the most recent trading day (a -3.74% change compared to the prior day closing price) with a volume of 10.86M shares and market capitalization of 195.81M. Is a component of indices and it is traded on NASDAQ exchange. The company belongs in the Medical Devices & Instruments industry, Healthcare sector and employs 932 people. Accuray Incorporated CEO is Joshua H. Levine.
The one-year performance of Accuray Incorporated stock is -55.51%, while year-to-date (YTD) performance is -56.81%. ARAY stock has a five-year performance of -55.41%. Its 52-week range is between 1.7 and 5.93, which gives ARAY stock a 52-week price range ratio of 9.69%
Accuray Incorporated currently has a PE ratio of -13.00, a price-to-book (PB) ratio of 3.22, a price-to-sale (PS) ratio of 0.39, a price to cashflow ratio of 19.50, a PEG ratio of 2.32, a ROA of -2.72%, a ROC of -4.79% and a ROE of -19.96%. The company’s profit margin is -3.01%, its EBITDA margin is 1.40%, and its revenue ttm is $430.82 Million , which makes it $4.64 revenue per share.
Of the last four earnings reports from Accuray Incorporated, there were 2 positive earnings surprise and 1 negative earnings surprise. The company has EPS estimate of $-0.05 for the next earnings report. Accuray Incorporated’s next earnings report date is 10th Aug 2022.
The consensus rating of Wall Street analysts for Accuray Incorporated is Strong Buy (1), with a target price of $7.4, which is +250.71% compared to the current price. The earnings rating for Accuray Incorporated stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
Accuray Incorporated has a dividend yield of -% with a dividend per share of $- and a payout ratio of -%.
Accuray Incorporated has a Neutral technical analysis rating based on Technical Indicators (ADX : 11.45, ATR14 : 0.16, CCI20 : 48.45, Chaikin Money Flow : -0.12, MACD : -0.11, Money Flow Index : 77.36, ROC : -6.36, RSI : 47.20, STOCH (14,3) : 57.14, STOCH RSI : 0.84, UO : 51.14, Williams %R : -42.86), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of Accuray Incorporated in the last 12-months were: Brandon W. Green (Sold 17 510 shares of value $69 165 ), Byron C. Scott (Buy at a value of $85 547), Jesse Chew (Sold 8 342 shares of value $43 629 ), Joseph E. Whitters (Buy at a value of $63 700), Joshua H. Levine (Buy at a value of $108 774), Joshua H. Levine (Sold 31 482 shares of value $124 669 ), Michael Hoge (Sold 11 653 shares of value $39 976 ), Patrick Spine (Sold 7 053 shares of value $32 865 ), Suzanne Winter (Buy at a value of $82 034), Suzanne Winter (Sold 46 880 shares of value $245 182 )
Copyright © 2016-2022 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex and Tradegate data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
eToro USA LLC does not offer CFDs and makes no representation and assumes no liability as to the accuracy or completeness of the content of this publication, which has been prepared by our partner utilizing publicly available non-entity specific information about eToro. Your capital is at risk.
This could take some time, please wait.